These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8148705)

  • 1. Diagnosing the undiagnosed with diabetes.
    Home PD
    BMJ; 1994 Mar; 308(6929):611-2. PubMed ID: 8148705
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 3. Finding undiagnosed type 2 diabetes: is it worth the effort?
    Engelgau MM; Narayan KM
    Eff Clin Pract; 2001; 4(6):281-3. PubMed ID: 11769302
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for type 2 diabetes: an update of the evidence.
    Simmons RK; Echouffo-Tcheugui JB; Griffin SJ
    Diabetes Obes Metab; 2010 Oct; 12(10):838-44. PubMed ID: 20920035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for type 2 diabetes. Undiagnosed diabetes must be detected.
    Streets P
    BMJ; 2001 Aug; 323(7310):453-4; author reply 454-5. PubMed ID: 11520852
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).
    Lee DS; Remington P; Madagame J; Blustein J
    WMJ; 2000 Jun; 99(3):39-43. PubMed ID: 10927980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.
    Chen L; Magliano DJ; Balkau B; Wolfe R; Brown L; Tonkin AM; Zimmet PZ; Shaw JE
    Diabet Med; 2011 Apr; 28(4):414-23. PubMed ID: 21392062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for type 2 diabetes. Screening would have important resource implications for primary care.
    Walker M; Thomson A; Whincup PH
    BMJ; 2001 Aug; 323(7310):454-5. PubMed ID: 11548729
    [No Abstract]   [Full Text] [Related]  

  • 11. [Screening for type 2 diabetes mellitus: more than looking for undiagnosed diabetes].
    González-Clemente JM
    Med Clin (Barc); 2004 Jul; 123(5):177-80. PubMed ID: 15274796
    [No Abstract]   [Full Text] [Related]  

  • 12. Opportunistic screening for diabetes.
    Easton JL; Segal L
    Med J Aust; 1998 Jan; 168(1):45. PubMed ID: 9451399
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-diabetes warnings going out. Diabetes epidemic on the uprise; pre-diabetes going undiagnosed.
    Cockey CD
    AWHONN Lifelines; 2002; 6(3):201, 203. PubMed ID: 12078560
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening and intervention. A strategy in type 2 diabetes?].
    Jørgensen T; Glümer C; Borch-Johnsen K
    Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a Screening Algorithm for Type II Diabetes Mellitus in the Resource-Limited Setting of Rural Tanzania.
    West C; Ploth D; Fonner V; Mbwambo J; Fredrick F; Sweat M
    Am J Med Sci; 2016 Apr; 351(4):408-15. PubMed ID: 27079348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040.
    Waldeyer R; Brinks R; Rathmann W; Giani G; Icks A
    Diabet Med; 2013 Aug; 30(8):999-1008. PubMed ID: 23506452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economics of screening and treatment in type 2 diabetes mellitus.
    Raikou M; McGuire A
    Pharmacoeconomics; 2003; 21(8):543-64. PubMed ID: 12751913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for diabetes: yes! but how?].
    Hauner H
    Dtsch Med Wochenschr; 2006 Oct; 131(40):2207. PubMed ID: 17021987
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes mellitus in China: a preventable economic burden.
    Wang W; McGreevey WP; Fu C; Zhan S; Luan R; Chen W; Xu B
    Am J Manag Care; 2009 Sep; 15(9):593-601. PubMed ID: 19747024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.